Cipta Sarana Medika Tbk. vs Putra Mandiri Jembar Tbk. — how do they compare? Cipta Sarana Medika Tbk. trades at Rp63 (market cap 158.12B, 8.21M 24h volume), while Putra Mandiri Jembar Tbk. trades at Rp109 (market cap 1.46T, 537.8K 24h volume). The key difference: Putra Mandiri Jembar Tbk. is far larger — about 9.2× Cipta Sarana Medika Tbk.'s market cap, and Cipta Sarana Medika Tbk. is more actively traded (8.21M versus 537.8K). Which is the better fit depends on your goals.
| DKHH | PMJS | |
|---|---|---|
Market Cap | 158.12B | 1.46T |
Volume | 8.21M | 537.8K |
Lot | 82.15K | 5.38K |
Turnover | 515.2M | 57.74M |
Average Price | 62.72 | 107.37 |
Value | 515.2M | 57.74M |
Indicative Equilibrium Price | 63 | 109 |
Indicative Equilibrium Volume | 1.33K | 759 |
Trailing returns across standard periods
Latest headlines on both assets
PT Cipta Sarana Medika Tbk (the Company) was established based on Deed No. 90 dated September 17, 2014 by Dede Fujianti, SH., M.Kn., Notary in Sukabumi. The Company ultimate parent entity is PT Siliwangi Djajakusumah Bersatu. The Company started its commercial operations in 2014.
Read more on DKHH →PT Putra Mandiri Jembar Tbk (the Company) was domiciled in Jakarta, established under the Deed No. 52 dated 18 July 2003 by notary Arikanti Natakusumah, S.H. PT Pahalamas Sejahtera is the parent entity and ultimate holding of the Company.
Read more on PMJS →